Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Delivering affordable cancer care in high-income countries.

Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M.

Lancet Oncol. 2011 Sep;12(10):933-80. doi: 10.1016/S1470-2045(11)70141-3.

PMID:
21958503
2.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology.

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.

PMID:
19581533
3.

Oral oncolytics: Part 2--legislation targeting cost & access, and other initiatives to reduce costs.

Mancini R, McBride A, Kruczynski M.

Oncology (Williston Park). 2013 Sep;27(9):865-6, 871. No abstract available.

PMID:
24282981
4.

How the Affordable Care Act Has Affected Cancer Care in the United States: Has Value for Cancer Patients Improved?

Schleicher SM, Wood NM, Lee S, Feeley TW.

Oncology (Williston Park). 2016 May;30(5):468-74. Review. No abstract available.

PMID:
27188679
5.

Expanding global access to radiotherapy.

Atun R, Jaffray DA, Barton MB, Bray F, Baumann M, Vikram B, Hanna TP, Knaul FM, Lievens Y, Lui TY, Milosevic M, O'Sullivan B, Rodin DL, Rosenblatt E, Van Dyk J, Yap ML, Zubizarreta E, Gospodarowicz M.

Lancet Oncol. 2015 Sep;16(10):1153-86. doi: 10.1016/S1470-2045(15)00222-3. Review.

PMID:
26419354
6.

From Obamacare to markets in artificial organs.

Malchesky PS.

Artif Organs. 2013 Mar;37(3):229-32. doi: 10.1111/aor.12055. No abstract available.

PMID:
23458329
7.

Economic burden of cancer across the European Union: a population-based cost analysis.

Luengo-Fernandez R, Leal J, Gray A, Sullivan R.

Lancet Oncol. 2013 Nov;14(12):1165-74. doi: 10.1016/S1470-2045(13)70442-X. Epub 2013 Oct 14.

PMID:
24131614
8.

Choosing wisely.

Bommer WJ.

Rev Cardiovasc Med. 2013;14(2-4):e134-5. No abstract available.

PMID:
24448254
9.

Preferences on policy options for ensuring the financial sustainability of health care services in the future: results of a stakeholder survey.

Tordrup D, Angelis A, Kanavos P.

Appl Health Econ Health Policy. 2013 Dec;11(6):639-52. doi: 10.1007/s40258-013-0056-7.

PMID:
24129648
10.

Economic incentives to promote innovation in healthcare delivery.

Luft HS.

Clin Orthop Relat Res. 2009 Oct;467(10):2497-505. doi: 10.1007/s11999-009-0930-7. Epub 2009 Jun 19.

11.

Cost of disorders of the brain in Europe 2010.

Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen HC, Stovner LJ, Vallat JM, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen HU, Jönsson B, Olesen J; CDBE2010Study Group.

Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79. doi: 10.1016/j.euroneuro.2011.08.008. Epub 2011 Sep 15. Erratum in: Eur Neuropsychopharmacol. 2012 Mar;22(3):237-8. den Bergh, Peter Van [corrected to Van den Bergh, Peter].

PMID:
21924589
12.

Regional collaboration as a model for fostering accountability and transforming health care.

Speir AM, Rich JB, Crosby I, Fonner E Jr.

Semin Thorac Cardiovasc Surg. 2009 Spring;21(1):12-9. doi: 10.1053/j.semtcvs.2009.03.005.

PMID:
19632558
13.

Drivers of the cost of cancer care.

Bergstrom R.

Lancet Oncol. 2012 Jan;13(1):14-5. doi: 10.1016/S1470-2045(11)70370-9. No abstract available.

PMID:
22225717
14.
15.

Does vascular surgery cost too much?

Clagett GP.

J Vasc Surg. 2009 Nov;50(5):1211-8. doi: 10.1016/j.jvs.2009.06.063. Epub 2009 Sep 26. No abstract available.

16.

Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts.

Pande AH, Ross-Degnan D, Zaslavsky AM, Salomon JA.

Am J Prev Med. 2011 Jul;41(1):1-8. doi: 10.1016/j.amepre.2011.03.010.

PMID:
21665057
17.

Delivery of affordable and equitable cancer care in India.

Pramesh CS, Badwe RA, Borthakur BB, Chandra M, Raj EH, Kannan T, Kalwar A, Kapoor S, Malhotra H, Nayak S, Rath GK, Sagar TG, Sebastian P, Sarin R, Shanta V, Sharma SC, Shukla S, Vijayakumar M, Vijaykumar DK, Aggarwal A, Purushotham A, Sullivan R.

Lancet Oncol. 2014 May;15(6):e223-33. doi: 10.1016/S1470-2045(14)70117-2. Epub 2014 Apr 11.

PMID:
24731888
18.

Socioeconomic disparities in access to ART treatment and the differential impact of a policy that increased consumer costs.

Chambers GM, Hoang VP, Illingworth PJ.

Hum Reprod. 2013 Nov;28(11):3111-7. doi: 10.1093/humrep/det302. Epub 2013 Aug 1.

PMID:
23906901
19.

Affordable cancer care.

Brábek J, Fernandes M.

Lancet Oncol. 2012 Jan;13(1):e2-3. doi: 10.1016/S1470-2045(11)70419-3. No abstract available.

PMID:
22225720
20.

Pricing-out effect from possible user-fee policies under Taiwan's National Health Insurance.

Chen WY, Liang YW, Lin YH.

Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):453-64. doi: 10.1586/erp.10.43. Review.

PMID:
20715921

Supplemental Content

Support Center